REFERENCES
- de Schryver I, Rozenberg F, Cassoux N, Michelson S, Kestelyn P, Lehoang P, Davis J L, Bodaghi B. Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br J Ophthalmol. 2006; 90: 852–855
- Mietz H, Aisenbrey S, Ulrich Bartz-Schmidt K, Bamborschke S, Krieglstein G K. Ganciclovir for the treatment of anterior uveitis. Graefes Arch Clin Exp Ophthalmol. 2000; 238: 905–909
- Markomichelakis N N, Canakis C, Zafirakis P, Marakis T, Mallias I, Theodossiadis G. Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy. Ophthalmology. 2002; 109: 879–882
- Teoh SC-B, Thean L, Koay E. Cytomegalovirus in aetiology of Posner–Schlossman syndrome: evidence from quantitative polymerase chain reaction. Eye. 2005; 19: 1338–1340
- Perry C M, Faulds D. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Drugs. 1996; 52: 754–772
- Ormrod D, Scott L J, Perry C M. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections. Drugs. 2000; 59: 839–863
- Lowance D, Neumayer H H, Legendre C M, Squifflet J P, Kovarik J, Brennan P J, Norman D, Mendez R, Keating M R, Coggon G L, Crisp A, Lee I C. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med. 1999; 340: 1462–1470
- Hodson E M, Jones C A, Webster A C, Strippoli G F, Barclay P G, Kable K, Vimalachandra D, Craig J C. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet. 2005; 365: 2105–2115
- Guex-Crosier Y, Meylan P R. High dosage of oral valaciclovir as an alternative treatment of varicella zoster acute retinal necrosis syndrome. Eye. 2006; 20: 247–2